ABL Bio Gastric Cancer Therapy Secures FDA Fast Track Business & Economy ABL Bio Gastric Cancer Therapy Secures FDA Fast Track editor 6월 17, 2026 (ABL Bio) ABL Bio announced Wednesday that its innovative gastric cancer treatment candidate, Givastomig (ABL111), has been...Read More
